Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study
- Resource Type
- Article
- Source
- In
Journal of Thoracic Oncology January 2023 - Subject
- Language
- ISSN
- 1556-0864